Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Teresa K. Chen"'
Autor:
Nityasree Srialluri, Aditya Surapaneni, Pascal Schlosser, Teresa K. Chen, Insa M. Schmidt, Eugene P. Rhee, Josef Coresh, Morgan E. Grams
Publikováno v:
Kidney Medicine, Vol 5, Iss 10, Pp 100714- (2023)
Rationale & Objective: Proteomics could provide pathophysiologic insight into the increased risk of mortality in patients with chronic kidney disease (CKD). This study aimed to investigate associations between the circulating proteome and all-cause m
Externí odkaz:
https://doaj.org/article/0a56a9c82ff94f9d8ae94c253cd5918a
Autor:
Jonathan J. Taliercio, Georges Nakhoul, Ali Mehdi, Wei Yang, Daohang Sha, Jesse D. Schold, Scott Kasner, Matthew Weir, Mohamed Hassanein, Sankar D. Navaneethan, Geetha Krishnan, Radhika Kanthety, Alan S. Go, Rajat Deo, Claudia M. Lora, Bernard G. Jaar, Teresa K. Chen, Jing Chen, Jiang He, Mahboob Rahman, Lawrence J. Appel, MD, MPH, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 4, Iss 11, Pp 100547- (2022)
Rationale and Objective: Chronic kidney disease is a risk enhancing factor for cardiovascular disease (CVD) and mortality, and the role of aspirin use is unclear in this population. We investigated the risk and benefits of aspirin use in primary and
Externí odkaz:
https://doaj.org/article/ff51643bfe34488d907e02835f2ed474
Autor:
Teresa K. Chen, Jessica Fitzpatrick, Cheryl A. Winkler, Elizabeth A. Binns-Roemer, Celia P. Corona-Villalobos, Bernard G. Jaar, Stephen M. Sozio, Rulan S. Parekh, Michelle M. Estrella
Publikováno v:
Kidney International Reports, Vol 6, Iss 2, Pp 333-341 (2021)
Introduction: To better understand the impact of APOL1 risk variants in end-stage renal disease (ESRD) we evaluated associations of APOL1 risk variants with subclinical cardiovascular disease (CVD) and mortality among African Americans initiating hem
Externí odkaz:
https://doaj.org/article/1138536a430048a690ee0423cb7355c5
Autor:
Teresa K. Chen, Ronit Katz, Michelle M. Estrella, Wendy S. Post, Holly Kramer, Jerome I. Rotter, Bamidele Tayo, Josyf C. Mychaleckyj, Christina L. Wassel, Carmen A. Peralta
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 17 (2020)
Background APOL1 high‐risk genotypes are associated with increased risk for hypertension‐attributed kidney disease among Black adults in the United States. Biopsy studies show differences in kidney vasculature by APOL1 status; less is known about
Externí odkaz:
https://doaj.org/article/740f3ae65fe14493a960a36e56506976
Autor:
Teresa K. Chen, Ronit Katz, Michelle M. Estrella, Orlando M. Gutierrez, Holly Kramer, Wendy S. Post, Michael G. Shlipak, Christina L. Wassel, Carmen A. Peralta
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 12 (2017)
BackgroundAPOL1 genetic variants confer an increased risk for kidney disease. Their associations with cardiovascular disease (CVD) are less certain. We aimed to compare the prevalence of subclinical CVD and incidence of atherosclerotic CVD and heart
Externí odkaz:
https://doaj.org/article/ca7b4f2c41ad4e5fa5949829cd7ae3ea
Autor:
Ruth F Dubin, Rajat Deo, Yue Ren, Hongzhe Lee, Haochang Shou, Harold Feldman, Paul Kimmel, Sushrut S Waikar, Eugene P Rhee, Adrienne Tin, Jingsha Chen, Joseph Coresh, Alan S Go, Tanika Kelly, Paduranga S Rao, Teresa K Chen, Mark R Segal, Peter Ganz
Publikováno v:
The Journal of Applied Laboratory Medicine. 8:491-503
Background We carried out a study of the aptamer proteomic assay, SomaScan V4, to evaluate the analytical and biological variability of the assay in plasma samples of patients with moderate to severe chronic kidney disease (CKD). Methods Plasma sampl
Autor:
Teresa K. Chen, Morgan E. Grams
Publikováno v:
Nephrology Self-Assessment Program. 21:135-145
Autor:
Teresa K. Chen, Steven G. Coca, Michelle M. Estrella, Lawrence J. Appel, Josef Coresh, Heather Thiessen Philbrook, Wassim Obeid, Linda F. Fried, Hiddo J.L. Heerspink, Joachim H. Ix, Michael G. Shlipak, Paul L. Kimmel, Chirag R. Parikh, Morgan E. Grams
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Higher baseline levels of soluble TNF receptors (TNFR1 and TNFR2) have been associated with progressive CKD. Whether longitudinal changes in these biomarkers of inflammation are also associated with worse kidney outcomes has been less stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de435ee02b325788b46ce3d86b6bcb0
https://europepmc.org/articles/PMC9063900/
https://europepmc.org/articles/PMC9063900/
Autor:
Jung Im Shin, Teresa K. Chen, Joseph A. Vassalotti, Morgan E. Grams, Alex R. Chang, Yao Qiao, Josef Coresh, Yingying Sang
Publikováno v:
Hypertension
Multiple clinical guidelines recommend an ACE (angiotensin-converting enzyme) inhibitor or angiotensin II receptor blocker (ARB) in patients with elevated albuminuria, which can be measured through urine albumin-to-creatinine ratio (ACR), protein-to-
Autor:
Elizabeth Binns-Roemer, Jessica Fitzpatrick, Bernard G. Jaar, Michelle M. Estrella, Cheryl A. Winkler, Stephen M. Sozio, Rulan S. Parekh, Celia P. Corona-Villalobos, Teresa K. Chen
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 6, Iss 2, Pp 333-341 (2021)
Kidney International Reports, Vol 6, Iss 2, Pp 333-341 (2021)
Introduction To better understand the impact of APOL1 risk variants in end-stage renal disease (ESRD) we evaluated associations of APOL1 risk variants with subclinical cardiovascular disease (CVD) and mortality among African Americans initiating hemo